All stock reports

ADANIENSOL evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-26T13:36:38.993306+00:00

Metrics

latest_annual_period
2026-03-31
revenue
275880300000.0
net_income
22825400000.0
operating_cash_flow
109966800000.0
free_cash_flow
-34351200000.0
total_assets
928349200000.0
total_liabilities
663092800000.0
total_equity
254275400000.0
cash
48825600000.0
total_debt
491764300000.0
revenue_growth
0.1607459766487851
earnings_growth
1.153400567940602
net_margin
0.08273660714447534
roe
0.08976645007735708
debt_to_equity
1.9339829963889545
cash_conversion
4.817738133833361
free_cash_flow_margin
-0.12451487112345463
trailing_pe
67.1099
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
7.8401
dividend_yield
Not supplied

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-7821b60fefe393e76cfb14f924c567b46b323f79a52b5aedf7d31550a82daddb
Policy
stock-decisions-v1
Evidence bundle hash
7625a84229ec3eb396f54c5a0ebb13074bbdd3a259d076e1d1cd100c40700b36
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 8d710f684429f7318c1540677012f37a128da3bf9b13517968405eb6b15747e5
  • daily-price: ef3d9a9df82041eecdc4ff259d03ff9dd3b0d7af9b1b3240b568a2d78ffeb6a2
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 5-session price return was -1.05%. The trailing 20-session price return was -5.03%. The trailing 60-session price return was -19.88%. The trailing 250-session price return was 50.86%. Average cached traded value over twenty sessions was INR 2,443,119,404.

Risks

The closing price was -23.84% below its highest close in the available trailing year. The cached financial metric free cash flow margin is -0.12451487112345463. The cached financial metric debt to equity is 1.9339829963889545. Financial data check: balance_sheet_equation: difference=10981000000.00. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.1607459766487851. The cached financial metric net margin is 0.08273660714447534. The cached financial metric roe is 0.08976645007735708. The cached financial metric cash conversion is 4.817738133833361.

Cached observations and evidence limits